Dritan Curi

Azienda Ospedaliero-Universitaria Careggi

Papers

1

Total Citations

18

H-Index

1

About

Dritan Curi is a leading researcher in nephrology and urology, with a focused expertise in renal biomarkers and the prediction of kidney function decline following surgical interventions. His most-cited work, "Novel Biomarkers for Early Detection of Acute Kidney Injury and Prediction of Long-Term Kidney Function Decline after Partial Nephrectomy" (2023, 18 citations), represents a pivotal contribution to the field. In this study, Curi and his team systematically compared serum biomarkers—including creatinine, kineticGFR, cystatin C, and neutrophil gelatinase-associated lipocalin—to identify early indicators of acute kidney injury (AKI) and, more importantly, to predict long-term eGFR decline. This dual focus on both immediate detection and chronic outcome prediction addresses a critical gap in postoperative renal care. By advancing the clinical utility of these biomarkers, Curi’s work has direct implications for improving patient management and long-term renal prognosis. His research is widely cited by clinicians and scientists seeking to refine risk stratification after nephrectomy, underscoring his impact on both surgical practice and translational nephrology.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Novel Biomarkers for Early Detection of Acute Kidney Injury and Prediction of Long-Term Kidney Function Decline after Partial Nephrectomy
18 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Azienda Ospedaliero-Universitaria Careggi

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago